VENTURE KICK PHASE II [July'17]
CTI Coaching Acceptance Phase III [June'17]
RetinAI is awarded with a Swiss CTI Grant [May'17]
Venture TOP25 [May'17]
ARVO 2017, Baltimore [May'17]
Our team members travelled to the American Research in Vision and Ophthalmology (ARVO) conference 2017, in Baltimore, to present their products in the field of OCT image analisys and Fundus Imaging. Many new collaborations coming along after this week!
CTI SATW Grant [April'17]
RetinAI in collaboration with the OTL (ARTORG Center, UniBern) recently received a Swiss grant to bring forward the study of ocular diseases such as Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR) and Glaucoma.
MICCAI 2017 [Feb'17]
Several submissions from the RetinAI team to MICCAI 2017. Hopefully meeting everybody in Quebec!
CTI Coaching [Dec'16]
RetinAI Medical has been selected to continue to the next phase of CTI Coaching, an initiative proposed by the swiss goverment to support promising start-ups in a variety of innovative fields.
Ypsomed Innovation PriCE 2016 Finalist [Dec'16]
Every two years, Ypsomed organizes a start-up competition to attract the attention of the most interesting start-ups in the region of Bern.
RETINET : Automatic AMD identification in OCT volumetric data [Oct'16]
Our new approach for achieving human level performance in the evaluation of AMD in OCT scans using convolutional neural network (CNNs) is out!